Journal
WORLD JOURNAL OF CLINICAL CASES
Volume 9, Issue 9, Pages 2100-2109Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.12998/wjcc.v9.i9.2100
Keywords
Ion channel drug; Neuropathic pain; Expert consensus; Guideline; Gabapentin; Carbamazepine; Oxcarbazepine; Lidocaine; Bulleyaconitine A; Pregabalin
Categories
Funding
- Sichuan Science and Technology Program [2018SZ0386]
Ask authors/readers for more resources
Neuropathic pain is a type of pain caused by disease or injury to the somatosensory system. Ion channel drugs are the main treatment, but irregular usage may lead to unsatisfactory pain relief. An expert consensus has been developed to guide the use of ion channel drugs for NPP in clinical practice.
Neuropathic pain (NPP) is a kind of pain caused by disease or damage impacting the somatosensory system. Ion channel drugs are the main treatment for NPP; however, their irregular usage leads to unsatisfactory pain relief. To regulate the treatment of NPP with ion channel drugs in clinical practice, the Chinese Association for the Study of Pain organized first-line pain management experts from China to write an expert consensus as the reference for the use of ion channels drugs . Here, we reviewed the mechanism and characteristics of sodium and calcium channel drugs, and developed recommendations for the therapeutic principles and clinical practice for carbamazepine, oxcarbazepine, lidocaine, bulleyaconitine A, pregabalin, and gabapentin. We hope this guideline provides guidance to clinicians and patients on the use of ion channel drugs for the management of NPP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available